Back to Sites

IMPAACT/ Gamma Project/ UPR Pediatric HIV/AIDS Research CRS

Site Number

5129

Address

Proyecto GAMMA
Biomedical Building II/ACTU
PR Medical Center grounds
First Floor, Suite 100
San Juan, PR 00935
United States of America

IMPAACT Members at this Site

Waleska Sanchez Clinical Research Assistant

Carmen Zorrilla Co-Investigator

Sylvia Davila-Nieves CRS Coordinator

Irma Febo-Rodriguez CRS Leader

Joanne Csedrik DAIDS PO

Carmen Irizarry Laboratory Manager/Supervisor

Wanda Ramon Pharmacist of Record

Esmeralda Barreto Pharmacy Technician

Yaritza Moran Research Nurse

Studies at this Site

A5241: Identifying Salvage Regimen w/ & w/o NRTIs Using cPSS and New Agents in the US

DAIDS Number

10395

Research Area

Antiretroviral Strategies

Study Status

Concluded

1077HS: HAART Standard Version of the PROMISE Study (Maternal & Infant Survival)

DAIDS Number

10779

Research Area

Therapeutics

Study Status

Concluded

P1026S: PK in Pregnancy

DAIDS Number

Therapeutics

Research Area

Treatment

Study Status

Closed to Follow Up

P1074: IMPAACT LTFU Study

DAIDS Number

10660

Research Area

Complications & Comorbidities

Study Status

Concluded

P1094: Evaluation of the use 3TC

DAIDS Number

11769

Research Area

Other

Study Status

Concluded

P1110: Safety and PK of RAL in Neonates

DAIDS Number

11891

Research Area

Treatment

Study Status

Concluded

P1112: Monoclonal Antibody PK Study

DAIDS Number

11903

Research Area

Therapeutics

Study Status

Participants Off Study and Primary Analysis Completed

P1115: Very Early Intensive Treatment of Infants Living with HIV to Achieve HIV Remission: A Phase I/II Proof of Concept Study

DAIDS Number

11954

Research Area

Cure and Immunotherapy

Study Status

Enrolling

IMPAACT 2015: Evaluation of the HIV-1 Reservoir in the Central Nervous System of Perinatally-Infected Youth and Young Adults with Cognitive Impairment

DAIDS Number

35123

Research Area

Cure and Immunotherapy

Study Status

Concluded

IMPAACT 2026: Pharmacokinetic Properties of Antiretroviral and Anti-Tuberculosis Drugs During Pregnancy and Postpartum.

DAIDS Number

38609

Research Area

Therapeutics

Study Status

Closed to Follow Up